The investment seeks long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category LargeGrowth
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
THNR | 22.55 | 0.05 | +0.21% |
Amplify Weight Loss Drug & Treatment ETF | |||
BALI | 31.02 | 0.04 | +0.13% |
iShares Advantage Large Cap Income ETF | |||
XTOC | 32.17 | -0.03 | -0.08% |
Innovator US Equity Acclrtd Pls ETF™ Oct | |||
DCOR | 69.88 | -0.12 | -0.17% |
Dimensional US Core Equity 1 ETF | |||
FCVT | 39.99 | -0.15 | -0.38% |
First Trust SSI Strat Convert Secs ETF |
A.I.dvisor indicates that over the last year, AKRSX has been closely correlated with GFACX. These tickers have moved in lockstep 87% of the time. This A.I.-generated data suggests there is a high statistical probability that if AKRSX jumps, then GFACX could also see price increases.
Ticker / NAME | Correlation To AKRSX | 1D Price Change % | ||
---|---|---|---|---|
AKRSX | 100% | N/A | ||
GFACX - AKRSX | 87% Closely correlated | -0.04% | ||
AGTHX - AKRSX | 71% Closely correlated | -0.05% | ||
GFFFX - AKRSX | 71% Closely correlated | -0.04% | ||
CGFAX - AKRSX | 71% Closely correlated | -0.05% | ||
RGABX - AKRSX | 70% Closely correlated | -0.05% | ||
More |